128 related articles for article (PubMed ID: 34580018)
1. KRAS mutation analysis by droplet digital PCR of duodenal juice from patients with MODY8 and other pancreatic diseases.
Choi MH; Tjora E; Forthun RB; Engjom T; Ræder H; Hovland R; Molven A
Pancreatology; 2021 Dec; 21(8):1460-1465. PubMed ID: 34580018
[TBL] [Abstract][Full Text] [Related]
2. Mutation analysis by deep sequencing of pancreatic juice from patients with pancreatic ductal adenocarcinoma.
Choi MH; Mejlænder-Andersen E; Manueldas S; El Jellas K; Steine SJ; Tjensvoll K; Sætran HA; Knappskog S; Hoem D; Nordgård O; Hovland R; Molven A
BMC Cancer; 2019 Jan; 19(1):11. PubMed ID: 30611220
[TBL] [Abstract][Full Text] [Related]
3. The Effect of Pancreatic Juice Collection Time on the Detection of KRAS Mutations.
Suenaga M; Dudley B; Karloski E; Borges M; Irene Canto M; Brand RE; Goggins M
Pancreas; 2018 Jan; 47(1):35-39. PubMed ID: 29200129
[TBL] [Abstract][Full Text] [Related]
4. KRAS and guanine nucleotide-binding protein mutations in pancreatic juice collected from the duodenum of patients at high risk for neoplasia undergoing endoscopic ultrasound.
Eshleman JR; Norris AL; Sadakari Y; Debeljak M; Borges M; Harrington C; Lin E; Brant A; Barkley T; Almario JA; Topazian M; Farrell J; Syngal S; Lee JH; Yu J; Hruban RH; Kanda M; Canto MI; Goggins M
Clin Gastroenterol Hepatol; 2015 May; 13(5):963-9.e4. PubMed ID: 25481712
[TBL] [Abstract][Full Text] [Related]
5. Detection of mutant KRAS and TP53 DNA in circulating exosomes from healthy individuals and patients with pancreatic cancer.
Yang S; Che SP; Kurywchak P; Tavormina JL; Gansmo LB; Correa de Sampaio P; Tachezy M; Bockhorn M; Gebauer F; Haltom AR; Melo SA; LeBleu VS; Kalluri R
Cancer Biol Ther; 2017 Mar; 18(3):158-165. PubMed ID: 28121262
[TBL] [Abstract][Full Text] [Related]
6. High prevalence of mutant KRAS in circulating exosome-derived DNA from early-stage pancreatic cancer patients.
Allenson K; Castillo J; San Lucas FA; Scelo G; Kim DU; Bernard V; Davis G; Kumar T; Katz M; Overman MJ; Foretova L; Fabianova E; Holcatova I; Janout V; Meric-Bernstam F; Gascoyne P; Wistuba I; Varadhachary G; Brennan P; Hanash S; Li D; Maitra A; Alvarez H
Ann Oncol; 2017 Apr; 28(4):741-747. PubMed ID: 28104621
[TBL] [Abstract][Full Text] [Related]
7. Characterization of KRAS Mutation in Acinar and Langerhans Islet Cells of Patients With Pancreatic Ductal Adenocarcinoma.
Wang Z; Zhang C; Nagee K; Mohammadi A; Monteiro C
Pancreas; 2016 Mar; 45(3):337-41. PubMed ID: 26474433
[TBL] [Abstract][Full Text] [Related]
8. Detection of K-ras gene mutations at codon 12 in the pancreatic juice of patients with intraductal papillary mucinous tumors of the pancreas.
Kondo H; Sugano K; Fukayama N; Hosokawa K; Ohkura H; Ohtsu A; Mukai K; Yoshida S
Cancer; 1997 Mar; 79(5):900-5. PubMed ID: 9041151
[TBL] [Abstract][Full Text] [Related]
9. Sensitive and quantitative detection of KRAS2 gene mutations in pancreatic duct juice differentiates patients with pancreatic cancer from chronic pancreatitis, potential for early detection.
Shi C; Fukushima N; Abe T; Bian Y; Hua L; Wendelburg BJ; Yeo CJ; Hruban RH; Goggins MG; Eshleman JR
Cancer Biol Ther; 2008 Mar; 7(3):353-360. PubMed ID: 18075308
[TBL] [Abstract][Full Text] [Related]
10. Two New Mutations in the CEL Gene Causing Diabetes and Hereditary Pancreatitis: How to Correctly Identify MODY8 Cases.
El Jellas K; Dušátková P; Haldorsen IS; Molnes J; Tjora E; Johansson BB; Fjeld K; Johansson S; Průhová Š; Groop L; Löhr JM; Njølstad PR; Molven A
J Clin Endocrinol Metab; 2022 Mar; 107(4):e1455-e1466. PubMed ID: 34850019
[TBL] [Abstract][Full Text] [Related]
11. Progression of Chronic Pancreatitis to Pancreatic Cancer: Is There a Role of Gene Mutations as a Screening Tool?
Rashid S; Singh N; Gupta S; Rashid S; Nalika N; Sachdev V; Bal CS; Datta Gupta S; Chauhan SS; Saraya A
Pancreas; 2018 Feb; 47(2):227-232. PubMed ID: 29303908
[TBL] [Abstract][Full Text] [Related]
12. [KRAS mutation assay on EUS-FNA specimens from pacients with pancreatic mass].
Bunganič B; Hálková T; Benešová L; Belšánová B; Laclav M; Hrůzová M; Traboulsi E; Frič P; Suchánek Š; Minárik M; Zavoral M
Cas Lek Cesk; 2016; 155(1):48-51. PubMed ID: 26898792
[TBL] [Abstract][Full Text] [Related]
13. Using an endoscopic distal cap to collect pancreatic fluid from the ampulla (with video).
Suenaga M; Sadakari Y; Almario JA; Borges M; Lennon AM; Shin EJ; Canto MI; Goggins M
Gastrointest Endosc; 2017 Dec; 86(6):1152-1156.e2. PubMed ID: 28259593
[TBL] [Abstract][Full Text] [Related]
14. Variant Profiling of Candidate Genes in Pancreatic Ductal Adenocarcinoma.
Huang J; Löhr JM; Nilsson M; Segersvärd R; Matsson H; Verbeke C; Heuchel R; Kere J; Iafrate AJ; Zheng Z; Ye W
Clin Chem; 2015 Nov; 61(11):1408-16. PubMed ID: 26378065
[TBL] [Abstract][Full Text] [Related]
15. Detection of point mutations in the K-ras oncogene at codon 12 in pure pancreatic juice for diagnosis of pancreatic carcinoma.
Kondo H; Sugano K; Fukayama N; Kyogoku A; Nose H; Shimada K; Ohkura H; Ohtsu A; Yoshida S; Shimosato Y
Cancer; 1994 Mar; 73(6):1589-94. PubMed ID: 8156485
[TBL] [Abstract][Full Text] [Related]
16. Mutant
Perets R; Greenberg O; Shentzer T; Semenisty V; Epelbaum R; Bick T; Sarji S; Ben-Izhak O; Sabo E; Hershkovitz D
Oncologist; 2018 May; 23(5):566-572. PubMed ID: 29371474
[TBL] [Abstract][Full Text] [Related]
17. KRAS variant allele frequency, but not mutation positivity, associates with survival of patients with pancreatic cancer.
Suzuki T; Masugi Y; Inoue Y; Hamada T; Tanaka M; Takamatsu M; Arita J; Kato T; Kawaguchi Y; Kunita A; Nakai Y; Nakano Y; Ono Y; Sasahira N; Takeda T; Tateishi K; Uemura S; Koike K; Ushiku T; Takeuchi K; Sakamoto M; Hasegawa K; Kitago M; Takahashi Y; Fujishiro M;
Cancer Sci; 2022 Sep; 113(9):3097-3109. PubMed ID: 35567350
[TBL] [Abstract][Full Text] [Related]
18. Nr5a2 heterozygosity sensitises to, and cooperates with, inflammation in KRas(G12V)-driven pancreatic tumourigenesis.
Flandez M; Cendrowski J; Cañamero M; Salas A; del Pozo N; Schoonjans K; Real FX
Gut; 2014 Apr; 63(4):647-55. PubMed ID: 23598351
[TBL] [Abstract][Full Text] [Related]
19. Concentrations of trace elements and KRAS mutations in pancreatic ductal adenocarcinoma.
Gómez-Tomás Á; Pumarega J; Alguacil J; Amaral AFS; Malats N; Pallarès N; Gasull M; Porta M;
Environ Mol Mutagen; 2019 Oct; 60(8):693-703. PubMed ID: 31066938
[TBL] [Abstract][Full Text] [Related]
20. Early detection of pancreatic cancer in patients with chronic pancreatitis: diagnostic utility of a K-ras point mutation in the pancreatic juice.
Queneau PE; Adessi GL; Thibault P; Cléau D; Heyd B; Mantion G; Carayon P
Am J Gastroenterol; 2001 Mar; 96(3):700-4. PubMed ID: 11280537
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
